Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA

mAbs

Volumn 1, Issue 3, 2009, Pages 190-209

  Reichert, Janice M ^a   Jacob, Nitya M ^b   Amanullah, Ashraf ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Minnesota   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; ERYTHROPOIETIN; IMMUNOGLOBULIN G; MK 2578; MONOCLONAL ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANEMIA; CAPILLARY ELECTROPHORESIS; CELL CULTURE; CELL LINE; CONFERENCE PAPER; DNA TRANSFECTION; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; ELECTROSPRAY MASS SPECTROMETRY; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; IMMUNOGENICITY; IMMUNOTOXICITY; INNATE IMMUNITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; NONHODGKIN LYMPHOMA; PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BIOENGINEERING; BIOPHARMACEUTICS; BIOTECHNOLOGY; CHEMISTRY TECHNIQUES, ANALYTICAL; COST-BENEFIT ANALYSIS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; SOCIETIES, SCIENTIFIC; UNITED STATES;

EID: 77953680558     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.1.3.8491     Document Type: Conference Paper

References (0)